Open AccessPretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma
Author(s) -
Steven I. Park,
Jaideep Shenoi,
Shani M. Frayo,
Donald K. Hamlin,
Yukang Lin,
D. Scott Wilbur,
Patrick S. Stayton,
Nural Orgun,
Mark D. Hylarides,
Franz Buchegger,
Aimee L. Kenoyer,
Amanda Axtman,
Ajay K. Gopal,
Damian J. Green,
John M. Pagel,
Oliver W. Press
Publication year - 2011
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/w76e-ms81
Subject(s) - radioimmunotherapy , streptavidin , genetically engineered , fusion protein , lymphoma , fusion , antibody , cancer research , medicine , chemistry , monoclonal antibody , immunology , recombinant dna , biochemistry , biotin , linguistics , philosophy , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom